Skip to main content
AbbottIn development

Abbott CardioMEMS Wins FDA Approval for Patient-Facing App Features

What happened

Abbott plans to make its CardioGuide HF App and a companion software feature, Dynamic Treatment Plan, available later this year.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Abbott announced on Oct. 5, 2026 that the U.S. Food and Drug Administration has approved updates to the CardioMEMS HF System that enable new patient-facing capabilities through the company's CardioGuide HF App. For the first time, care teams can allow U.S. CardioMEMS patients to view their pulmonary artery pressure (PAP) readings directly on their smartphones. The CardioGuide HF App is a mobile application for people living with heart failure who have an implanted CardioMEMS pulmonary artery pressure sensor. It displays a patient's own PAP readings and trends on an iOS or Android smartphone. Abbott said it plans to make the CardioGuide HF App and a companion software feature, Dynamic Treatment Plan, available later this year. Pulmonary artery pressure is the pressure of blood flowing from the right side of the heart into the lungs. According to Abbott, rising PAP is one of the earliest signs of worsening heart failure and can occur weeks before a patient experiences symptoms. For more than a decade, clinicians have used PAP readings from the CardioMEMS HF System to help identify signs of worsening heart failure and guide treatment. The CardioMEMS HF System measures PAP through a small sensor implanted permanently in the pulmonary artery. The system also includes the CardioMEMS HERO device, which patients use to take pressure readings, and the Merlin.net Patient Care Network...

Keep reading with a free account

The rest of this article, and every signal for Abbott, is in your free account.

Extracted by Autobound

From the Signal API record
Event
In development

What this signalsWork in development often leads to new buying for tools, data and services.

Product
CardioGuide HF App

More in development signals at other companies

The full record

From the Signal API record

Topics and mentions

Product tags

  • online technology
  • general technology
  • medical
  • mobile

Extraction

Confidence
90%
Detected
Oct 5, 2026
signal_type
news
signal_subtype
is_developing

Use this data

Get every in development signal for Abbott and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Abbott this week?”

  2. Send it to your own tools

    The Signal API returns in development signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/4370bbac-e2cb-163f-0c0a-7ce97430c4d0 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbott.com.

{
  "signal_id": "4370bbac-e2cb-163f-0c0a-7ce97430c4d0",
  "signal_type": "news",
  "signal_subtype": "is_developing",
  "detected_at": "2026-10-05T13:12:02+00:00",
  "company": {
    "name": "Abbott",
    "domain": "abbott.com"
  },
  "data": {
    "url": "https://www.securities.io/abbott-cardiomems-wins-fda-approval-for-patient-facing-app-features/",
    "title": "Abbott CardioMEMS Wins FDA Approval for Patient-Facing App Features - Securities.io",
    "excerpt": "Abbott announced on Oct. 5, 2026 that the U.S. Food and Drug Administration has approved updates to the CardioMEMS HF System that enable new patient-facing capabilities through the company’s CardioGuide HF App. For the first time, care teams can allow U.S. CardioMEMS patients to view their pulmonary artery pressure (PAP) readings directly on their smartphones. The CardioGuide HF App is a mobile application for people living with heart failure who have an implanted CardioMEMS pulmonary artery pressure sensor. It displays a patient’s own PAP readings and trends on an iOS or Android smartphone. Abbott said it plans to make the CardioGuide HF App and a companion software feature, Dynamic Treatment Plan, available later this year. Pulmonary artery pressure is the pressure of blood flowing from the right side of the heart into the lungs. According to Abbott, rising PAP is one of the earliest signs of worsening heart failure and can occur weeks before a patient experiences symptoms. For more than a decade, clinicians have used PAP readings from the CardioMEMS HF System to help identify signs of worsening heart failure and guide treatment. The CardioMEMS HF System measures PAP through a small sensor implanted permanently in the pulmonary artery. The system also includes the CardioMEMS HERO device, which patients use to take pressure readings, and the Merlin.net Patient Care Network...",
    "product": "CardioGuide HF App",
    "summary": "Abbott plans to make its CardioGuide HF App and a companion software feature, Dynamic Treatment Plan, available later this year.",
    "planning": true,
    "image_url": "https://www.securities.io/wp-content/uploads/2026/10/abbott-cardiomems-wins-fda-approval-for-patient-facing-app-features.jpg",
    "confidence": 0.9,
    "product_data": {
      "name": "CardioGuide HF App",
      "full_text": "CardioGuide HF App",
      "fuzzy_match": false
    },
    "product_tags": [
      "online_technology",
      "general_technology",
      "medical",
      "mobile"
    ],
    "published_at": "2026-10-05T13:12:02Z",
    "article_sentence": "Abbott said it plans to make the CardioGuide HF App and a companion software feature, Dynamic Treatment Plan, available later this year."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.